Table of Contents
- Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
- FAQ
- FAQ
- Does cannabis use actually worsen cognitive performance in multiple sclerosis patients?
- Why do MS patients who use cannabis report more cognitive problems if their test scores are similar?
- Should I be concerned about cannabis affecting my ability to accurately assess my own cognitive function?
- Are the cognitive effects of cannabis the same for everyone with MS?
- What should I discuss with my neurologist about cannabis use and cognition?
Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
Cannabis users with multiple sclerosis report greater perceived cognitive deficits despite no clear differences in objective cognitive performance.
This study demonstrates that cannabis use in MS patients is associated with increased subjective complaints of cognitive dysfunction, independent of mood and fatigue factors. The cross-sectional design identifies an association but cannot establish whether cannabis causes these perceptual differences or whether people with greater cognitive concerns are more likely to use cannabis.
This finding is clinically relevant because patient-reported cognitive symptoms significantly impact quality of life and treatment decisions in MS care. Understanding that cannabis users may perceive greater cognitive deficits helps clinicians contextualize patient complaints and assess whether subjective reports align with objective testing.
| Study Type | Cross-sectional Study |
| Population | 847 people with multiple sclerosis (254 cannabis users, 593 non-users) |
| Intervention | Cannabis use (observational comparison) |
| Comparator | Non-cannabis users |
| Primary Outcome | Discrepancies between subjective and objective cognitive performance |
| Key Finding | Cannabis users reported greater perceived cognitive deficits than non-users |
| Journal | Multiple Sclerosis and Related Disorders |
| Year | 2024 |
People with MS who use cannabis report more cognitive problems than non-users, even when controlling for depression, anxiety, and fatigue. This perception-reality gap warrants careful clinical evaluation to distinguish between actual cognitive decline and heightened awareness or concern about cognitive function.
The abstract does not establish causation or indicate whether cannabis actually impairs cognitive function in this population. We cannot determine if cannabis use leads to cognitive complaints, if cognitively concerned patients seek cannabis treatment, or if the relationship is bidirectional.
Cross-sectional studies cannot determine temporal relationships or causation. The abstract does not specify cannabis formulations, dosing, or duration of use, all of which could influence cognitive effects. Selection bias may exist if patients with cognitive concerns are more likely to try cannabis.
Cannabis use in MS patients correlates with increased subjective cognitive complaints, but this association requires careful clinical interpretation. Clinicians should neither dismiss these concerns nor assume they indicate objective impairment without proper cognitive assessment.
Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
FAQ
Does cannabis use actually worsen cognitive performance in multiple sclerosis patients?
This study found no clear differences in objective cognitive performance between cannabis users and non-users with MS. However, previous research has shown detrimental effects of cannabis on objective cognitive measures in MS populations, suggesting mixed evidence that requires further investigation.
Why do MS patients who use cannabis report more cognitive problems if their test scores are similar?
Cannabis users with MS reported greater perceived cognitive deficits despite showing no significant differences on objective cognitive tests. This discrepancy suggests that cannabis use may affect self-awareness of cognitive functioning or that subjective experiences don’t always align with measurable cognitive performance.
Should I be concerned about cannabis affecting my ability to accurately assess my own cognitive function?
Yes, this study suggests cannabis users may have reduced insight into their actual cognitive abilities. The discrepancy between self-reported and objective cognitive functioning could impact treatment decisions and daily functioning assessments.
Are the cognitive effects of cannabis the same for everyone with MS?
Individual responses likely vary, as this study controlled for factors like anxiety, depression, fatigue, and premorbid IQ that can influence cognitive function. Your specific MS disease course, cannabis use patterns, and other health factors may all influence how cannabis affects your cognition.
What should I discuss with my neurologist about cannabis use and cognition?
Discuss both your subjective cognitive concerns and request objective cognitive testing if you use cannabis. Consider how cannabis may be affecting your self-assessment of cognitive function, and work together to monitor any changes in both perceived and measured cognitive abilities over time.
